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DITORIALhe medical literature and the discipline of
nfection control
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rnfection control was put to the test when severe
cute respiratory syndrome (SARS) spread from
sia, particularly affecting Canada and the United
tates. From late 2002 to the spring of the 2003,
he virulent pathogen infected 8098 people, caus-
ng 774 deaths [1,2] and igniting alarm before its
pread was arrested.
The advent of SARS set the stage for another
care when avian inﬂuenza A (H5N1) threatened to
park a pandemic. Governments around the world
rafted plans to impose quarantines and stockpile
ntiviral agents, while hospital managers planned
or a surge of patients [3—5]. To date, though, the
orld has been spared a global problem.*
Both episodes led to a ﬂurry of scientiﬁc papers
6], adding to the growing body of infection con-
rol and prevention literature already augmented
y increased publication by researchers and prac-
itioners from countries with maturing health care
ystems like Brazil and China.
The ﬁeld’s expanding knowledge base, along
ith the rising pace of globalization, demonstrates
he need for additional outlets for the dissemina-
ion of research. The launch, then, of the Journal
f Infection and Public Health is a welcome addi-
ion to the community of peer-reviewed scientiﬁc
ublications.
Despite groundbreaking advancements in micro-
iology and epidemiology, yielding insights into
he mechanisms driving the transmission of infec-
ious diseases, clinicians and practitioners continue
o struggle with rendering those gains into com-
ensurate breakthroughs in the reduction of
ealthcare-associated infections (HAI) [7,8]. In a
* The authors wrote this commentary before the outbreak of
wine inﬂuenza A (H1N1) in late April 2009.
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levens et al. [9] estimated 1.7 million episodes
f HAIs in U.S. hospitals during 2002, resulting
n 98,987 deaths. Other countries, both devel-
ped and developing, and especially resource-poor
ations, confront similar challenges. The stubborn
ersistence of these high mortality rates demand
ncreased research and publication that translates
esearch ﬁndings into improved patient outcomes.
o that end, the addition of JIPH to the ﬁeld of
nfection control journals is an auspicious step.
Indeed, in light of the strain that HAIs place
n healthcare systems [10], the current number
f peer-reviewed journals might seem inadequate.
resently, three journals publish the bulk of infec-
ion control and prevention-related papers: Journal
f Hospital Infection, American Journal of Infec-
ion Control and Infection Control and Hospital
pidemiology. In the United States, for example,
he Centers for Disease Control and Prevention
ttributed 14,627 deaths to AIDS in 2006 [11].
et, the number of AIDS-related publications far
xceeds the two U.S. infection control journals
AJIC and ICHE) even though nearly seven times as
any people died from HAIs. With the continued
hreat of emerging and the persistence of reemerg-
ng diseases, the opportunity for HAIs to burden the
ealth care system will not diminish [12].
Not only does the persistence of HAI justify a
obust infection prevention literature, the chang-
ng dynamics of infectious disease themselves pose
ew challenges that will spur research and pub-
ication. The emergence of multidrug-resistant
rganisms (MDRO), the increasing prevalence of
ethicillin-resistant Staphylococcus aureus (MRSA)
nd Clostridium difﬁcile-associated disease, along
ith the continuing threat of pandemic inﬂuenza
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[54
provide fertile ground for researchers and practi-
tioners to expand the scope of the literature.
Of course, adding to the body of published
research is not an end in itself. The value from these
endeavors will show when health ofﬁcials confront
the next outbreak or when patients see meaningful
reduction in the probability that they will avoid a
preventable disease.
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